Arrhythmias & electrophysiology

Appropriateness of implantable cardioverter-defibrillator device implants in the United States

Heart RhythmPublished Retrospective cohort study

Authors' conclusion

In this large national registry, 95% of mappable ICD and CRT-D implants were considered appropriate, with <2% of RA implants.

Study context

Population
Patients undergoing implantable cardioverter-defibrillator (ICD) implantation at >1500 US hospitals, April 2018–March 2019243,532 (79%) mappable to AUC
Participants
309,318 patients
Exposure
Primary prevention vs Secondary prevention
  • Primary preventionn = 241,438
  • Secondary preventionn = 67,880
Outcome
Proportion of ICD and CRT-D implants appropriate, may be appropriate (MA) or rarely appropriate (RA) by appropriate use criteria
Methodological detailsmulticentre, registry-based (National Cardiovascular Data Registry), >1500 US hospitals
  • Multicentre
  • Registry-based (National Cardiovascular Data Registry)
  • >1500 US hospitals

Main finding

As reported in the abstract

Appropriateness of ICD implants by AUC
GroupAppropriateMARarely appropriate (RA)
Primary prevention185,431 (96.4%)5660 (2.9%)1205 (0.6%)
Secondary prevention47,498 (92.7%)2581 (5%)1157 (2.3%)

Appropriate

Primary prevention185,431 (96.4%)
Secondary prevention47,498 (92.7%)

MA

Primary prevention5660 (2.9%)
Secondary prevention2581 (5%)

Rarely appropriate (RA)

Primary prevention1205 (0.6%)
Secondary prevention1157 (2.3%)

Observational data: associations, not effects.

Further findings

Indications among RA implants

NYHA class IV HF ineligible for advanced therapies
53.9%
MI within 40 days
18.1%

Appropriateness of dual-chamber pacing lead

Appropriate
48,470 (62%)
MA
29,209 (37.4%)
RA
448 (0.6%)

Appropriateness of cardiac resynchronization therapy with defibrillator (CRT-D) for LV pacing

Appropriate
63,848 (82.2%)
MA
9900 (12.7%)
RA
3940 (5.1%)

Appropriate implants excluded from CMS National Coverage Determination

Appropriate but excluded from CMS NCD
99,754

Hospital-level RA implant rate

Hospitals with RA implant rate <4%
>92%

Original publication

Appropriateness of implantable cardioverter-defibrillator device implants in the United States. Heart Rhythm. Published 18 December 2023. doi:10.1016/j.hrthm.2023.12.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.